Cargando…

Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35

Alzheimer's disease (AD) has become one of the major diseases endangering the health of the elderly. Clarifying the features of each AD animal model is valuable for understanding the onset and progression of diseases and developing potential treatments in the pharmaceutical industry. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Mengying, Liu, Yuanyuan, Pi, Zifeng, Yue, Kexin, Li, Shizhe, Hu, Mingxin, Liu, Zhiqiang, Song, Fengrui, Liu, Zhongying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064735/
https://www.ncbi.nlm.nih.gov/pubmed/35515227
http://dx.doi.org/10.1039/c9ra00302a
_version_ 1784699447772446720
author Wei, Mengying
Liu, Yuanyuan
Pi, Zifeng
Yue, Kexin
Li, Shizhe
Hu, Mingxin
Liu, Zhiqiang
Song, Fengrui
Liu, Zhongying
author_facet Wei, Mengying
Liu, Yuanyuan
Pi, Zifeng
Yue, Kexin
Li, Shizhe
Hu, Mingxin
Liu, Zhiqiang
Song, Fengrui
Liu, Zhongying
author_sort Wei, Mengying
collection PubMed
description Alzheimer's disease (AD) has become one of the major diseases endangering the health of the elderly. Clarifying the features of each AD animal model is valuable for understanding the onset and progression of diseases and developing potential treatments in the pharmaceutical industry. In this study, we aimed to clarify plasma metabolomics and neurotransmitter dysfunction in the process of AD model rat induced by amyloid beta 25-35 (Aβ 25-35). Firstly, Morris Water Maze (MWM) test was used to investigate cognitive impairment in AD rat after 2, 4 and 8 weeks of modelling. Based on this, the effects on levels of AD-related enzymes and eight neurotransmitters were analyzed. And plasma metabolomics analysis based on ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF-MS) was used to research the metabolic disturbances in the process of AD rat. The results shown the injury on the spatial learning ability of AD rats was gradually aggravated within 4 weeks, reached the maximum at 4 weeks and then was stable until 8 weeks. During 8 weeks of modeling, the levels of enzymes including β-secretase, γ-secretase, glycogen synthase kinase-3β (GSK-3β), acetyl cholinesterase (AchE) and nitric oxide synthase (NOS) were significant increased in the plasma of AD rats. The neurotransmitter dysfunction was mainly involved in γ-aminobutyric acid (GABA), acetyl choline (Ach), glutamic acid (Glu), 5-hydroxytryptamine (5-HT), dopamine (DA) and norepinephrine (NE). 17 endogenous metabolites correlated with AD were successfully detected in the metabolomics analysis. These metabolites were mainly involved in fatty acids, sphingolipids, and sterols metabolisms, vitamin metabolism, and amino acid metabolism. These metabolites might be the potential biomarkers that correctly mark different stages of AD. The study on peripheral plasma indices reflecting the process of AD laid the foundation for understand the pathophysiology of AD and find an effective and radical cure. And the rules of endogenous metabolic disorder in AD rats also have a certain guiding significance for the future study of food–drug interactions at different stages of AD.
format Online
Article
Text
id pubmed-9064735
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-90647352022-05-04 Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35 Wei, Mengying Liu, Yuanyuan Pi, Zifeng Yue, Kexin Li, Shizhe Hu, Mingxin Liu, Zhiqiang Song, Fengrui Liu, Zhongying RSC Adv Chemistry Alzheimer's disease (AD) has become one of the major diseases endangering the health of the elderly. Clarifying the features of each AD animal model is valuable for understanding the onset and progression of diseases and developing potential treatments in the pharmaceutical industry. In this study, we aimed to clarify plasma metabolomics and neurotransmitter dysfunction in the process of AD model rat induced by amyloid beta 25-35 (Aβ 25-35). Firstly, Morris Water Maze (MWM) test was used to investigate cognitive impairment in AD rat after 2, 4 and 8 weeks of modelling. Based on this, the effects on levels of AD-related enzymes and eight neurotransmitters were analyzed. And plasma metabolomics analysis based on ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF-MS) was used to research the metabolic disturbances in the process of AD rat. The results shown the injury on the spatial learning ability of AD rats was gradually aggravated within 4 weeks, reached the maximum at 4 weeks and then was stable until 8 weeks. During 8 weeks of modeling, the levels of enzymes including β-secretase, γ-secretase, glycogen synthase kinase-3β (GSK-3β), acetyl cholinesterase (AchE) and nitric oxide synthase (NOS) were significant increased in the plasma of AD rats. The neurotransmitter dysfunction was mainly involved in γ-aminobutyric acid (GABA), acetyl choline (Ach), glutamic acid (Glu), 5-hydroxytryptamine (5-HT), dopamine (DA) and norepinephrine (NE). 17 endogenous metabolites correlated with AD were successfully detected in the metabolomics analysis. These metabolites were mainly involved in fatty acids, sphingolipids, and sterols metabolisms, vitamin metabolism, and amino acid metabolism. These metabolites might be the potential biomarkers that correctly mark different stages of AD. The study on peripheral plasma indices reflecting the process of AD laid the foundation for understand the pathophysiology of AD and find an effective and radical cure. And the rules of endogenous metabolic disorder in AD rats also have a certain guiding significance for the future study of food–drug interactions at different stages of AD. The Royal Society of Chemistry 2019-06-10 /pmc/articles/PMC9064735/ /pubmed/35515227 http://dx.doi.org/10.1039/c9ra00302a Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Wei, Mengying
Liu, Yuanyuan
Pi, Zifeng
Yue, Kexin
Li, Shizhe
Hu, Mingxin
Liu, Zhiqiang
Song, Fengrui
Liu, Zhongying
Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35
title Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35
title_full Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35
title_fullStr Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35
title_full_unstemmed Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35
title_short Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35
title_sort investigation of plasma metabolomics and neurotransmitter dysfunction in the process of alzheimer's disease rat induced by amyloid beta 25-35
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064735/
https://www.ncbi.nlm.nih.gov/pubmed/35515227
http://dx.doi.org/10.1039/c9ra00302a
work_keys_str_mv AT weimengying investigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT liuyuanyuan investigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT pizifeng investigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT yuekexin investigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT lishizhe investigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT humingxin investigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT liuzhiqiang investigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT songfengrui investigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535
AT liuzhongying investigationofplasmametabolomicsandneurotransmitterdysfunctionintheprocessofalzheimersdiseaseratinducedbyamyloidbeta2535